Insulin-like Growth Factor I Plasmid Therapy Promotes in Vivo Angiogenesis

Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat. Med., 1, 27, 10.1038/nm0195-27

Horvath, 2002, Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging, Ann. Thoracic Surg., 74, 481, 10.1016/S0003-4975(02)03736-0

Davis, 2003, Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering, Nat. Struct. Biol., 10, 38, 10.1038/nsb880

Peters, 1998, Vascular endothelial growth factor and the angiopoietins: Working together to build a better blood vessel, Circ. Res., 83, 342, 10.1161/01.RES.83.3.342

Veikkola, 2000, Regulation of angiogenesis via vascular endothelial growth factor receptors, Cancer Res., 60, 203

Cheng, 1996, Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells, J. Neurochem., 66, 525, 10.1046/j.1471-4159.1996.66020525.x

Menetrey, 2000, Growth factors improve muscle healing in vivo, J. Bone Joint Surg. Br., 82, 131, 10.1302/0301-620X.82B1.8954

De Luca, 1999, Higher content of insulin-like growth factor-I in dystrophic mdx mouse: Potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function, Neuromusc. Disord., 9, 11, 10.1016/S0960-8966(98)00092-3

Fiorelli, 1996, Characterization and function of the receptor for IGF-I in human preosteoclastic cells, Bone, 18, 269, 10.1016/8756-3282(95)00485-8

Spoerri, 1998, Insulin-like growth factor: Receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin, Growth Horm. IGF Res., 8, 125, 10.1016/S1096-6374(98)80102-0

Kobayashi, 2002, Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats, Am. J. Physiol. Heart Circ. Physiol., 283, H1761, 10.1152/ajpheart.00248.2002

Punglia, 1997, Regulation of vascular endothelial growth factor expression by insulin-like growth factor I, Diabetes, 46, 1619, 10.2337/diacare.46.10.1619

Akeno, 2002, Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha, Endocrinology, 143, 420, 10.1210/endo.143.2.8639

Miele, 2000, Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways, J. Biol. Chem., 275, 21695, 10.1074/jbc.M000805200

Reinmuth, 2002, Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer, Lab. Invest., 82, 1377, 10.1097/01.LAB.0000032411.41603.C2

Wu, 2002, Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis, Cancer Res., 62, 1030

Bermont, 2000, Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells, Int. J. Cancer, 85, 117, 10.1002/(SICI)1097-0215(20000101)85:1<117::AID-IJC21>3.0.CO;2-X

Castellon, 2002, Effects of angiogenic growth factor combinations on retinal endothelial cells, Exp. Eye Res., 74, 523, 10.1006/exer.2001.1161

Shigematsu, 1999, IGF-1 regulates migration and angiogenesis of human endothelial cells, Endocr. J., 46, S59, 10.1507/endocrj.46.Suppl_S59

Arthur, 1998, Growth factors reverse the impaired sprouting of microvessels from aged mice, Microvasc. Res., 55, 260, 10.1006/mvre.1998.2078

Walsh, 1996, Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide, Endocrinology, 137, 1798, 10.1210/endo.137.5.8612517

Rabinovsky, 2003, Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration, FASEB J., 17, 53, 10.1096/fj.02-0183fje

Jabri, 1994, Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients, Diabetes, 43, 369, 10.2337/diab.43.3.369

Zhuang, 1996, Insulin-like growth factors reverse or arrest diabetic neuropathy: Effects on hyperalgesia and impaired nerve regeneration in rats, Exp. Neurol., 140, 198, 10.1006/exnr.1996.0129

Glazner, 1994, Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration, Brain Res. Mol. Brain Res., 25, 265, 10.1016/0169-328X(94)90162-7

Alila, 1997, Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats, Hum. Gene Ther., 8, 1785, 10.1089/hum.1997.8.15-1785

Fewell, 2001, Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation, Mol. Ther., 3, 574, 10.1006/mthe.2001.0295

Draghia-Akli, 1999, Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs, Nat. Biotechnol., 17, 1179, 10.1038/70718

Draghia-Akli, 2002, Enhanced animal growth via ligand-regulated GHRH myogenic-injectable vectors, FASEB J., 16, 426, 10.1096/fj.01-0702fje

Macchi, 2003, A GFP-based system to uncouple mRNA transport from translation in a single living neuron, Mol. Biol. Cell, 14, 1570, 10.1091/mbc.E02-08-0505

Gramolini, 2001, Distinct regions in the 3′ untranslated region are responsible for targeting and stabilizing utrophin transcripts in skeletal muscle cells, J. Cell Biol., 154, 1173, 10.1083/jcb.200101108

Wong, 2001, A single point mutation at the 3′-untranslated region of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated responses, J. Biol. Chem., 276, 33129, 10.1074/jbc.M105400200

Haas, 2002, Molecular control of capillary growth in skeletal muscle, Can. J. Appl. Physiol., 27, 491, 10.1139/h02-027

Dimmeler, 2000, Endothelial cell apoptosis in angiogenesis and vessel regression, Circ. Res., 87, 434, 10.1161/01.RES.87.6.434

Hang, 1995, VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle, Am. J. Physiol., 269, H1827

Gustafsson, 1999, Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle, Am. J. Physiol., 276, H679

Milkiewicz, 2003, Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: Favourable effect of muscle activity, Clin. Sci. (London), 10.1042/CS20030035

Hoke, 2001, Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum, Exp. Neurol., 172, 398, 10.1006/exnr.2001.7808

Florini, 1991, Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression, Mol. Endocrinol., 5, 718, 10.1210/mend-5-5-718

Ishii, 1994, Role of insulin-like growth factors in peripheral nerve regeneration, Pharmacol. Ther., 62, 125, 10.1016/0163-7258(94)90007-8

Russell, 2000, Insulin-like growth factor-I promotes myelination of peripheral sensory axons, J. Neuropathol. Exp. Neurol., 59, 575, 10.1093/jnen/59.7.575

Cheng, 2000, IGF-I promotes Schwann cell motility and survival via activation of Akt, Mol. Cell Endocrinol., 170, 211, 10.1016/S0303-7207(00)00324-5

Takahashi, 2002, Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth, Mol. Cell. Biol., 22, 4803, 10.1128/MCB.22.13.4803-4814.2002

Gustafsson, 2002, Increased expression of vascular endothelial growth factor in human skeletal muscle in response to short-term one-legged exercise training, Pflügers Arch., 444, 752, 10.1007/s00424-002-0845-6

Hudlicka, 2002, Hypoxia and expression of VEGF-A protein in relation to capillary growth in electrically stimulated rat and rabbit skeletal muscles, Exp. Physiol., 87, 373, 10.1113/eph8702285

Gille, 2001, Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): A reassessment using novel receptor-specific vascular endothelial growth factor mutants, J. Biol. Chem., 276, 3222, 10.1074/jbc.M002016200

Autiero, 2003, Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: Novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders, J. Thromb. Haemostasis, 1, 1356, 10.1046/j.1538-7836.2003.00263.x

Shibuya, 2001, Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1), Int. J. Biochem. Cell Biol., 33, 409, 10.1016/S1357-2725(01)00026-7

Kremer, 1997, Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system, Cancer Res., 57, 3852

Rivard, 1999, Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF, Am. J. Pathol., 154, 355, 10.1016/S0002-9440(10)65282-0

Currie, 1998, The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes, Diabetes Care, 21, 42, 10.2337/diacare.21.1.42

Lorenzi, 1985, Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death, Diabetes, 34, 621, 10.2337/diab.34.7.621

Holzenberger, 2003, IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice, Nature, 421, 182, 10.1038/nature01298

Wilson, 2001, Modulation of retinal endothelial cell behavior by insulin-like growth factor I and somatostatin analogues: Implications for diabetic retinopathy, Growth Horm. IGF Res., 11, S53, 10.1016/S1096-6374(01)80009-5

Tamatani, 1998, Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide, Cell Death Differ., 5, 911, 10.1038/sj.cdd.4400439

Han, 2003, Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development, Am. J. Respir. Cell Mol. Biol., 28, 159, 10.1165/rcmb.4764

Coleman, 1995, Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice, J. Biol. Chem., 270, 12109, 10.1074/jbc.270.20.12109